← All trials
NCT05069246
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 8, 2020
- Primary completion
- Dec 24, 2020
- Completion date
- Feb 28, 2021
- First posted
- Oct 6, 2021
- Last posted
- Oct 6, 2021
- Enrollment
- 37
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Princess Nourah Bint Abdulrahman UniversityLead sponsor
- Princess Nourah Bint Abdulrahman UniversitySponsor investigator
- Princess Nourah Bint Abdulrahman UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.